Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Furue

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study]Y Ishihara, N Nukariya, K Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]T Taguchi, H Furue, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Host factors in cancer chemotherapy]H Furue, M Kako, H Mugitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1994
[Study of cardiac function in first stage examination of RA-700. RA-700 Clinical Study Group]F Yoshida, R Asai, H Majima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1994
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies]R Ohno, Y Yoshida, M Oguro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study]N Nukariya, K Kobayashi, Y Ishihara, et al.
Internal Medicine (Tokyo, Japan)|June 1, 1992
Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiencyC Murakami, M Ishibashi, M Kondo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]Y Akasaka, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]M Ikeda, T Taguchi, K Ota, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study]Y Ishihara, N Nukariya, K Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]T Taguchi, H Furue, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1986
[Host factors in cancer chemotherapy]H Furue, M Kako, H Mugitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1994
[Study of cardiac function in first stage examination of RA-700. RA-700 Clinical Study Group]F Yoshida, R Asai, H Majima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1994
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies]R Ohno, Y Yoshida, M Oguro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study]N Nukariya, K Kobayashi, Y Ishihara, et al.
Internal Medicine (Tokyo, Japan)|June 1, 1992
Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiencyC Murakami, M Ishibashi, M Kondo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]Y Akasaka, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]M Ikeda, T Taguchi, K Ota, et al.
Pageof 15